Consensus Statement on the Management of Duchenne Muscular Dystrophy in Saudi Arabia During the Coronavirus Disease 2019 Pandemic

Frontiers in Pediatrics

Tahani Ahmed Jamaly¹  Musaad Abukhaled²  Sameer Al-Mehmadi³  Fahad A. Bashiri⁴  Fouad Alghamdi⁵  Ahmed K. Bamaga⁶  Osama Y. Muthaffar⁶  Waleed Altwaijri⁷  Nahla Alshaikh⁸  Abdulaziz Al-Saman⁹  Mohammad A. Al-Muhaizea^1,10  Khalid Hundallah^1,10 

[1] Children Health Center, International Medical Center, Jeddah, Saudi Arabia;Department of Neuroscience, King Faisal Specialist Hospital and Research Centre, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia;Department of Pediatric Neurology, Children's Hospital, King Saud Medical City, Riyadh, Saudi Arabia;Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia;Division of Neurology, Department of Pediatrics, King Saud University Medical City, Riyadh, Saudi Arabia;King Fahad Specialist Hospital, Dammam, Saudi Arabia;Neurology Division, Pediatric Department, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia;Pediatric Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia;Pediatric Department, King Saud Bin Abdulaziz University, Riyadh, Saudi Arabia;Pediatric Department, King Abdullah Specialized Children Hospital, Riyadh, Saudi Arabia;Pediatric Department, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia;College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia;King Abdullah International Medical Research Center, Jeddah, Saudi Arabia;Pediatric Neurology Department, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia;Prince Sultan Military Medical City, Riyadh, Saudi Arabia;

关键词: COVID-19;    Duchenne muscular dystrophy;    consensus;    telemedicine;    virtual clinic;   

DOI  :  10.3389/fped.2021.629549

来源: Frontiers

【 授权许可】

CC BY